chr17-75846769-G-T
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_012478.4(WBP2):c.751C>A(p.Pro251Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
WBP2
NM_012478.4 missense
NM_012478.4 missense
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 5.27
Publications
0 publications found
Genes affected
WBP2 (HGNC:12738): (WW domain binding protein 2) The globular WW domain is composed of 38 to 40 semiconserved amino acids shared by proteins of diverse functions including structural, regulatory, and signaling proteins. The domain is involved in mediating protein-protein interactions through the binding of polyproline ligands. This gene encodes a WW domain binding protein that is a transcriptional coactivator of estrogen receptor alpha and progesterone receptor. Defects in this gene have been associated with hearing impairment. [provided by RefSeq, Jan 2017]
WBP2 Gene-Disease associations (from GenCC):
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
- hearing loss, autosomal recessive 107Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32665545).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012478.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WBP2 | MANE Select | c.751C>A | p.Pro251Thr | missense | Exon 8 of 8 | NP_036610.2 | |||
| WBP2 | c.751C>A | p.Pro251Thr | missense | Exon 9 of 9 | NP_001335099.1 | Q969T9-1 | |||
| WBP2 | c.616C>A | p.Pro206Thr | missense | Exon 7 of 7 | NP_001317428.1 | Q969T9-2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WBP2 | TSL:1 MANE Select | c.751C>A | p.Pro251Thr | missense | Exon 8 of 8 | ENSP00000254806.3 | Q969T9-1 | ||
| WBP2 | TSL:5 | c.751C>A | p.Pro251Thr | missense | Exon 9 of 9 | ENSP00000467579.1 | Q969T9-1 | ||
| WBP2 | TSL:3 | c.739C>A | p.Pro247Thr | missense | Exon 8 of 8 | ENSP00000466450.1 | K7EMC9 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of phosphorylation at P251 (P = 0.0019)
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.